Cargando…
Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity
OBJECTIVES: Cholesteatoma is a nonneoplastic destructive lesion of the temporal bone with debated pathogenesis and bone resorptive mechanism. Both molecular and cellular events chiefly master its activity. Continued research is necessary to clarify factors related to its aggressiveness. We aimed to...
Autores principales: | Hamed, Mahmood A., Nakata, Seiichi, Shiogama, Kazuya, Suzuki, Kenji, Sayed, Ramadan H., Nishimura, Yoichi, Iwata, Noboru, Sakurai, Kouhei, Badawy, Badawy S., Inada, Ken-ichi, Tsuge, Hayato, Tsutsumi, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Otorhinolaryngology-Head and Neck Surgery
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545701/ https://www.ncbi.nlm.nih.gov/pubmed/28073243 http://dx.doi.org/10.21053/ceo.2016.01263 |
Ejemplares similares
-
Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives
por: Hamed, Mahmood A., et al.
Publicado: (2016) -
Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015) -
Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
por: Kim, Hyung-Jong, et al.
Publicado: (2002) -
Cytokeratin 17 and Ki-67: Immunohistochemical markers for the differential diagnosis of keratoacanthoma and squamous cell carcinoma
por: Leblebici, Cem, et al.
Publicado: (2017) -
Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers
por: Adisa, James Olayiwola, et al.
Publicado: (2015)